FlorentLe Prado

Collaborateur

Paris + 33.1.56.59.38.04

Contact

Partager

Florent Le Prado intervient dans les domaines du private equity, des fusions-acquisitions et du droit boursier. Il assiste principalement des entreprises à fort potentiel de croissance cotées et non cotées et leurs actionnaires dirigeants, financiers ou industriels, à tous les stades de leur développement, depuis leur création jusqu'à leur adossement industriel ou leur introduction en bourse et, au-delà, dans leur vie de sociétés cotées.

Les entreprises récemment représentées par Florent Le Prado comptent notamment Adikteev, Alizé Pharma, Cellectis, EasyVista, ETS Global, Eurobio Scientific, Inside Secure, Ivalua, Lacroix Group, Ouicar, Pharnext, SuperSonic Imagine, TxCell, Urban Canopée et Welcome to the Jungle ; et les investisseurs stratégiques ou financiers Alven Capital Partners, Bpifrance, ChapsVision, Creadev (famille Mulliez), Elaia Partners, Idinvest Partners, New Alpha Asset Management, Open CNP, Portage Ventures, Ring Capital, Seventure Partners et Temasek.

Parmi les opérations représentatives de son expérience figurent les OPAs d’EasyVista, SuperSonic Imagine, Coheris, TxCell et Orolia ; les introductions en bourse de Medincell et Pharnext ; les LBOs d’EasyVista par Eurazeo, Brico Privé par Florac et Orolia par Eurazeo ; les derniers tours de financement d’Actility, Contentsquare, InnovaFeed, Ivalua, Urban Canopée, UroMems et Welcome to the Jungle ; les acquisitions d’eSoftThings par Lacroix Group et Pipplet par ETS Global, et la cession d’Alizé Pharma à Millendo.

Expérience

  • Tikehau Capital co-leads €8.5 million fundraising for OSS VenturesJones Day advised Tikehau Capital in connection with the €8.5 million fundraising of OSS Ventures, a leading industrial start-up studio in France, for propelling the future of operations, also led by France 2030's French Tech Accélération 2 fund (Bpifrance) and Etablissements Peugeot.
  • Doctolib acquires Aaron.aiJones Day advised Doctolib, the leading healthtech company in Europe, in its acquisition of the Berlin company Aaron.ai, the current market leader in Germany for AI-based telephone assistance solutions for medical practices, relieving doctors and practice staff of answering telephone calls and offering patients telephone access to doctors' practices around the clock.
  • Serena invests in KotzillaJones Day advised Serena Capital in the $2 million seed financing of Kotzilla, a French company engaged in the development and marketing of an application monitoring developer platform.
  • Radial Equity acquires Moss Motors and Rimmer BrosJones Day advised Radial Equity Partners in the acquisition and financing of Moss Motors, a U.S.-headquartered aftermarket supplier of parts for British cars, and Rimmer Bros, a UK-based supplier of replacement parts for UK marque vehicles.
  • Cellectis and AstraZeneca enter into research collaboration and agree on equity investment of up to $220 million by AstraZenecaJones Day advised Cellectis in connection with the joint research collaboration agreement entered into with AstraZeneca and initial equity investment by AstraZeneca into Cellectis of $80 million.
  • NANO Corp raises €4.2 million in seed financingJones Day advised NANO Corp, a cybersecurity firm providing software-based network detection and response (NDR) solutions, in connection with its €4.2 million seed financing, led by G+D Ventures.
  • Contentsquare acquires HeapJones Day acted as French counsel to Contentsquare in the acquisition of Heap, a leading U.S. product analytics platform.
  • DJUST raises €12 million in Series A financingJones Day represented DJUST, a B2B eCommerce SaaS platform, in connection with its €12 million Series A growth funding led by New Enterprise Associates, Inc. (NEA), with additional participation from Elaia Partners.
  • Sofinnova and NVentures co-lead $55.4 million financing of Moon SurgicalJones Day advised Sofinnova Partners (through Sofinnova Capital Strategy) and NVentures (NVIDIA's venture capital arm) as lead investors in connection with the $55.4 million financing of Moon Surgical, a French-American pioneer in collaborative robotics.
  • CVE raises €100 million from ICG InfraJones Day advised CVE, a France-based independent producer of renewable energy across multiple countries and sources of power, in connection with its €100 million financing round led by Intermediate Capital Group plc, a global alternative asset manager, through its infrastructure investment arm (ICG Infra).
  • Portage and Orange Ventures lead €37 million Series C financing of MooncardJones Day advised Portage and Orange Ventures as lead investors in connection with the €37 million Series C financing of Mooncard, the French leader in the automation of corporate spend, in which historical investors Aglaé Ventures, BlackFin Capital Partners, Partech Partners and RAISE Ventures also participated.
  • Welcome to the Jungle raises €50 million in Series C financingJones Day represented Welcome to the Jungle, a company that develops and operates a recruitment and employer branding solution, in connection with its €50 million Series C financing led by Cipio Partners and Blisce alongside new investors, Kostogri, Groupe ADP, and Raise Sherpas, and existing investors, Revaia, XAnge, and Bpifrance (Digital Venture).
  • Fintecture raises €26 million in Series A financingJones Day advised Fintecture, a pioneering next-gen B2B payment platform, in connection with its €26 million Series A financing led by new investors Eurazeo, RTP Global, HEC Ventures, Allianz Trade with existing investors Target Global, Samaipata and Business Angels also participating.
  • Macquarie agrees to acquire Suez Recycling and Recovery UK Group for approximately €2.4 billionJones Day advised Macquarie Asset Management in the execution of a put option agreement to acquire 100% of the shares of Suez Recycling and Recovery UK Group for €2.4 billion.
  • Eurobio Scientific acquires GenDxJones Day advised Eurobio Scientific SA in the acquisition and financing of the Dutch company Genome Diagnostics BV (GenDx) from its founder and its shareholders for €135 million (net of adjusted cash).
  • Doctolib acquires Vettore RinascimentoJones Day advised Doctolib, the leading e-health company in Europe, in its acquisition of Vettore Rinascimento, an Italian company specializing in the development of software for the healthcare sector.
  • Creadev and Temasek invest in InnovafeedJones Day advised Creadev SAS and Temasek, investors in the $250 million Series D financing of Innovafeed, a leader in the production of insects (Hermetia Illucens) for animal and plant nutrition.
  • 2050 invests in TilliJones Day advised 2050 in connection with the €1.2 million round of financing of Tilli, a French-based company that develops and operates a platform connecting people in the fields of sewing.
  • Elaia Partners invests in SUN ZU LabJones Day advised Elaia Partners in connection with the €1.5 million first round of financing with Kima Ventures in SUN ZU Lab, a French Fintech that produces liquidity analytics to enable cryptocurrency investors to optimize their transactions.
  • Adikteev acquires minority interest in TemprJones Day advised Adikteev in its acquisition of a minority interest in Tempr, a SaaS company that helps mobile advertisers realize the full potential of their user acquisition operations and maximize their returns.
    •

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.